Krka Temporarily Banned from Producing, Marketing Zolrix in Slovenia
Novo Mesto, 4 February - The Ljubljana District Court has issued a temporary injunction banning drug maker Krka from manufacturing and marketing in Slovenia Zolrix or other products containing the active ingredient olanzapine, the company said in a press release on Monday.
The rest of this news item is available to subscribers.
The news item consists of 679 characters (without spaces) or 129 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.